General Information of the Compound
Compound ID
CP0014868
Compound Name
4-[4-(3,8,10-triazatricyclo[7.3.0.02,6]dodeca-1,4,6,8,11-pentaen-3-yl)pyrazol-1-yl]butanenitrile
    Show/Hide
Formula
C16H14N6
Molecular Weight
290.33
Canonical SMILES
N#CCCCn1cc(cn1)-n1ccc2cnc3[nH]ccc3c12
    Show/Hide
InChI
InChI=1S/C16H14N6/c17-5-1-2-7-21-11-13(10-20-21)22-8-4-12-9-19-16-14(15(12)22)3-6-18-16/h3-4,6,8-11H,1-2,7H2,(H,18,19)
    Show/Hide
InChIKey
QLSATRPSVBYFAY-UHFFFAOYSA-N
Physicochemical Property
logP
3.00708
Rotatable Bonds
4
Heavy Atom Count
22
Polar Areas
75.22
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4872996
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01214, Tyrosine-protein kinase JAK2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000128 TF-1 Homo sapiens (Human)  1
1
IC50 = 269 nM
   TI
   LI
   LO
   TS